Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Murdoch

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Ambio|October 26, 2022
Foresight science in conservation: Tools, barriers, and mainstreaming opportunitiesGabrielle Ednie, Tyreen Kapoor, Olga Koppel, et al.
Pulmonary Pharmacology & Therapeutics|June 22, 1999
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinicT J Torphy, M S Barnette, D C Underwood, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 7, 2017
Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
Jaclyn A Smith, Lorcan P A McGarvey, Huda Badri, et al.
Journal of Clinical Pharmacology|September 11, 2001
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteersB D Zussman, L J Benincosa, D M Webber, et al.
Heart (British Cardiac Society)|August 18, 2009
Secondhand smoke exposure and survival following acute coronary syndrome: prospective cohort study of 1261 consecutive admissions among never-smokersJ P Pell, S Haw, S Cobbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Cell Reports|October 11, 2016
Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome SystemJohn D Murdoch, Christine M Rostosky, Sindhuja Gowrisankaran, et al.
Pharmacotherapy|June 13, 2001
Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilastB D Zussman, C C Davie, J Kelly, et al.
Internal Medicine Journal|October 21, 2015
Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experienceV Subban, D Murdoch, M L Savage, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Ambio|October 26, 2022
Foresight science in conservation: Tools, barriers, and mainstreaming opportunitiesGabrielle Ednie, Tyreen Kapoor, Olga Koppel, et al.
Pulmonary Pharmacology & Therapeutics|June 22, 1999
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinicT J Torphy, M S Barnette, D C Underwood, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 7, 2017
Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
Jaclyn A Smith, Lorcan P A McGarvey, Huda Badri, et al.
Journal of Clinical Pharmacology|September 11, 2001
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteersB D Zussman, L J Benincosa, D M Webber, et al.
Heart (British Cardiac Society)|August 18, 2009
Secondhand smoke exposure and survival following acute coronary syndrome: prospective cohort study of 1261 consecutive admissions among never-smokersJ P Pell, S Haw, S Cobbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Cell Reports|October 11, 2016
Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome SystemJohn D Murdoch, Christine M Rostosky, Sindhuja Gowrisankaran, et al.
Pharmacotherapy|June 13, 2001
Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilastB D Zussman, C C Davie, J Kelly, et al.
Internal Medicine Journal|October 21, 2015
Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experienceV Subban, D Murdoch, M L Savage, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
Pageof 16